Transluminal balloon angioplasty of pulmonary arteries in patients with inoperable chronic thromboembolic pulmonary hypertension (first experience in Russia)

Cover Page

Cite item

Full Text

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe disease, based on the persistent violation of ventilation-perfusion ratio and increase in pulmonary vascular resistance. The only way to stop the progression of right ventricular heart failure in patients with CTEPH was thromboendarterectomy, until later. In some cases, thromboendarterectomy was contraindicated in patients with lesions of distal branches of the pulmonary vascular tree, despite the high efficiency of surgical treatment. The method of endovascular correction of thrombosis in distal branches of the pulmonary artery (transluminal balloon angioplasty) was appeared several years ago. This method demonstrated the high efficiency and safety in patients with inoperable CTEPH. This article deals with the first experience of angioplasty of pulmonary arteries application in Russia.

About the authors

N. M Danilov

Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation

Email: ndanilov1@gmail.com
канд. мед. наук, ст. науч. сотр. отд. гипертонии ФГБУ РКНПК 121552, Russian Federation, Moscow, ul. 3-ia Cherepkovskaia, d. 15a

Yu. G Matchin

Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation

д-р мед. наук, рук. лаб. рентгенэндоваскулярных методов диагностики и лечения в амбулаторных условиях научно-диспансерного отд. ФГБУ РКНПК 121552, Russian Federation, Moscow, ul. 3-ia Cherepkovskaia, d. 15a

T. V Martynyuk

Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation

д-р мед. наук, рук. лаб. легочной гипертензии ФГБУ РКНПК 121552, Russian Federation, Moscow, ul. 3-ia Cherepkovskaia, d. 15a

I. S Fedotenkov

Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation

зав. кабинетом компьютерной томографии ИКК им. А.Л.Мясникова ФГБУ РКНПК, канд. мед. наук 121552, Russian Federation, Moscow, ul. 3-ia Cherepkovskaia, d. 15a

I. E Chazova

Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation

чл.-кор. РАН, д-р мед. наук, проф. дир. ИКК им. А.Л.Мясникова ФГБУ РКНПК 121552, Russian Federation, Moscow, ul. 3-ia Cherepkovskaia, d. 15a

References

  1. UK National Specialised Commissioning Team. Service Specification 2011/2012.
  2. Kim N.H, Delcroix M, Jenkins D.P et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 2013; 62 (25 Suppl.): D92-9. doi: 10.1016/j.jacc.2013.10.024
  3. Pepke-Zaba J, Delcroix M, Lang I et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 2011; 124 (18): 1973-81. doi:10.1161/ CIRCULATIONAHA.110.015008
  4. Feinstein J.A, Goldhaber S.Z, Lock J.E et al. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation 2001; 103 (1): 10-3. doi: 10.1161/01.CIR.103.1.10
  5. Mizoguchi H, Ogawa A, Munemasa M et al. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012; 5 (6): 748-55. doi: 10.1161/CIRCINTERVENTIONS.112.971077
  6. Sugimura K, Fukumoto Y, Satoh K et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long - term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J 2012; 76 (2): 485-8. doi: 10.1253/circj.CJ-11-1217
  7. Kataoka M, Inami T, Hayashida K et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 2012; 5 (6): 756-62. doi: 10.1161/CIRCINTERVENTIONS.112.971390
  8. Kim N.H, Delcroix M, Jenkins D.P et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 2013; 62 (25 Suppl): D92-9.
  9. Konstantinides S.V, Torbicki A, Agnelli G et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35: 3033-69.
  10. Jamieson S.W., Kapelanski D.P, Sakakibara N et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003; 76: 1457-62.
  11. Ghofrani H.A, D’Armini A.M, Grimminger F et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 2013; 369 (4): 319-29. doi: 10.1056/NEJMoa1209657
  12. Ghofrani H.A, Schermuly R.T, Rose F, Wiedemann R. Sildenafil for long - term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2003; 167: 1139-41.
  13. Kitani M, Ogawa A, Sarashina T et al. Histological changes of pulmonary arteries treated by balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 2014; 7: 857-9. doi: 10.1161/CIRCINTERVENTIONS.114.001533
  14. Andreassen A.K, Ragnarsson A, Gude E et al. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart 2013; 99 (19): 1415-20. doi: 10.1136/heartjnl-2012-303549
  15. Inami T, Kataoka M, Shimura N et al. Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty. JACC Cardiovasc Interv 2013; 6 (7): 725-36. doi: 10.1016/j.jcin.2013.03.009
  16. Fukui S, Ogo T, Morita Y et al. Right ventricular reverse remodelling after balloon pulmonary angioplasty. Eur Respir J 2014; 43 (5): 1394-402. doi: 10.1183/09031936.00012914
  17. Tsugu T, Murata M, Kawakami T et al. Significance of echocardiographic assessment for right ventricular function after balloon pulmonary angioplasty in patients with chronic thromboembolic induced pulmonary hypertension. Am J Cardiol 2015; 115 (2): 256-61. doi: 10.1016/j.amjcard.2014.10.034

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies